ICMR Transfers Three Indigenous Medical Technologies to Industry at National Technology Day 2026

<h3>Overview</h3> <p>The <span class="key-term" data-definition="Indian Council of Medical Research — India's apex body for biomedical research, responsible for coordinating and funding health research (GS3: Science &amp; Technology)">ICMR</span> participated in the national programme <span class="key-term" data-definition="‘विज्ञान–Tech’ programme — A government‑led platform that brings together 14 scientific ministries and departments to showcase indigenous technologies (GS3: Science &amp; Technology)">विज्ञान–Tech</span> on the occasion of <span class="key-term" data-definition="National Technology Day — Annual observance on 11 May to celebrate India's achievements in science, technology and innovation (GS3: Science &amp; Technology)">National Technology Day</span> 2026. The event, held at the BRIC‑National Institute of Immunology, New Delhi, was coordinated by the <span class="key-term" data-definition="Principal Scientific Adviser (PSA) — The chief scientific advisor to the Government of India, overseeing coordination of scientific policy across ministries (GS3: Science &amp; Technology)">Principal Scientific Adviser</span> and the <span class="key-term" data-definition="Department of Biotechnology (DBT) — Ministry of Science &amp; Technology department that promotes biotechnology research and development (GS3: Science &amp; Technology)">Department of Biotechnology</span>, reflecting a whole‑of‑government approach.</p> <h3>Key Developments</h3> <ul> <li>Six high‑impact indigenous technologies were displayed, including <span class="key-term" data-definition="Covaxin — India's indigenous COVID‑19 vaccine developed by ICMR and Bharat Biotech (GS3: Science &amp; Technology)">Covaxin</span>, a COVID‑Kavach ELISA kit, a <span class="key-term" data-definition="CRISPR‑Cas system — A gene‑editing technology used for precise detection of pathogens, exemplified by the TB detection system (GS3: Science &amp; Technology)">CRISPR‑Cas</span>‑based TB detection system, a Nipah point‑of‑care assay, a dengue ELISA kit, and a biolarvicide for mosquito control.</li> <li>A compendium of 25 promising technologies from various ICMR institutes was released, covering diagnostics, medical devices, digital health, disease surveillance and translational research.</li> <li>Three ICMR‑developed technologies were licensed to industry under the Medical Innovations Patent Mitra initiative:</li> <ul> <li>Cost‑effective PSP94 ELISA for prostate biopsy decisions – licensed to <strong>Krishgen Labs Pvt. Ltd.</strong></li> <li>Factor VIII inhibitor/coagulation disorder point‑of‑care diagnostic – licensed to <strong>Meril Life Sciences</strong></li> <li>Single‑tube multiplex real‑time RT‑PCR for dengue, chikungunya and Zika – licensed to <strong>Vanguard Life Sciences</strong></li> </ul> </ul> <h3>Important Facts</h3> <p>The technology transfer session was part of a broader MoU exchange that showcased innovations from autonomous institutes of 14 scientific ministries. The licensing agreements aim to protect publicly funded inventions while enabling rapid commercialisation, aligning with the <strong>Make in Bharat</strong> vision.</p> <h3>UPSC Relevance</h3> <p>For GS‑3 (Science &amp; Technology) aspirants, the event illustrates how India leverages public‑private partnerships to translate research into market‑ready health solutions. It underscores the role of institutions like ICMR in addressing national health priorities, the importance of intellectual‑property frameworks such as the Medical Innovations Patent Mitra, and the policy thrust of self‑reliant healthcare ecosystems under the <strong>Viksit Bharat</strong> agenda.</p> <h3>Way Forward</h3> <p>To sustain momentum, the government should:</p> <ul> <li>Strengthen IP support for academic innovators and streamline licensing processes.</li> <li>Encourage scale‑up of licensed products through incentives for domestic manufacturing.</li> <li>Integrate these indigenous technologies into national health programmes such as the Ayushman Bharat scheme.</li> <li>Expand the <span class="key-term" data-definition="‘विज्ञान–Tech’ programme — A government‑led platform that brings together 14 scientific ministries and departments to showcase indigenous technologies (GS3: Science &amp; Technology)">विज्ञान–Tech</span> platform to include more private sector participation and cross‑border collaborations.</li> </ul> <p>These steps will deepen the innovation ecosystem, improve health security, and reinforce India’s position as a global hub for affordable medical technologies.</p>